Glaukos saw the highest growth of 149% in patent filings in February and 299% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Glaukos‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Glaukos has been focused on protecting inventions in United States(US) with ten publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 62% filings and 56% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Glaukos is filings its patents. Among the top granted patent authorities, Glaukos has 56% of its grants in United States(US), 22% in European Patent Office(EPO) and 22% in Australia(AU).

AbbVie and F. Hoffmann-La Roche could be the strongest competitors for Glaukos

In terms of grant share, Glaukos stands in fourth position among its competitors. AbbVie and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.

Patents related to cell & gene therapy and healthtech lead Glaukos's portfolio

Glaukos has the highest number of patents in cell & gene therapy followed by, healthtech and smart materials. For cell & gene therapy no patents were filed and 25% of patents were granted in Q1 2024.

Ophthalmic devices related patents lead Glaukos portfolio followed by drug delivery devices, and petrochemicals

Glaukos has highest number of patents in ophthalmic devices followed by drug delivery devices, petrochemicals, diagnostic imaging, and implantable systems. For ophthalmic devices, nearly 60% of patents were filed and 50% of patents were granted in Q1 2024.

For comprehensive analysis of Glaukos's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.